Media Publications - Critical Path Institute

August 6, 2024

C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium

TUCSON, Ariz., August 6, 2024 — Critical Path Institute’s (C-Path) Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) co

Vivli’s Clinical Trials Data Platform and RDCA-DAP Will Make Data More Widely Accessible by Having Specific Data Sets Available

TUCSON, Ariz., August 22, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Critical Path for Lysosomal Diseas

The event, scheduled for Wed., July 3, is supported by C-Path’s CDRC, xCures and hummel as sponsors. TUCSON, Ariz., July 1,

July 18, 2024

Join us on Thursday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD)...

June 20, 2024

C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...

June 20, 2024

C-Path announced the targeted integration of additional Friedreich’s ataxia...

June 24, 2024-June 25, 2024

C-Path's Executive Director, Critical Path for Parkinson's (CPP) Consortium, Diane Stephenson will join as a...

June 12, 2024

Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD).

June 12, 2024

Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and...